Swander Pace Capital (SPC) has sold over-the-counter (OTC) products portfolio company Insight Pharmaceuticals to Prestige Brands Holdings for USD750 million.
The sale of Insight represents the firm’s second platform investment in the OTC industry.
“Today’s sale is the culmination of a successful five-year partnership to build a world-class OTC company,” says Mo Stout, managing director at SPC. “During our ownership, Insight grew sales from approximately USD80 million to more than USD200 million. We want to thank the management team at Insight for all of their hard work in creating significant value for the company’s stakeholders.”
“We are extremely proud of our partnership with Swander Pace, which was essential in supporting our growth and providing industry best practices and new business opportunities,” says Gary Downing, CEO of Insight. “We look forward to the next phase in our development and would like to thank Swander Pace and its investment partner, the Ontario Teachers’ Pension Plan, for their tireless commitment and support over the past five years.”
Under the ownership of SPC and Teachers’, Insight expanded its product portfolio of OTC women’s health and personal care products. The Insight portfolio consists of nearly 30 OTC brands.
